IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer

Oncotarget

Volumn 5, Issue 16, 2014, Pages 6832-6845

  Taniuchi, Keisuke ^a   Furihata, Mutsuo ^a   Hanazaki, Kazuhiro ^a   Saito, Motoaki ^a   Saibara, Toshiji ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

Cell invasion and metastasis; Cell protrusion; Local translation; Pancreatic cancer; RNA binding protein; Stress granule

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; FIBRONECTIN; INITIATION FACTOR; MESSENGER RNA; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 4; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG; IMP3 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL DIFFERENTIATION; CELL GRANULE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DENDRITE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; LIVER METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PANCREAS METASTASIS; PANCREATIC CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR INVASION; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; CELL SURFACE; DISEASE COURSE; GENETIC TRANSFECTION; GENETICS; METABOLISM; METASTASIS; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURFACE EXTENSIONS; DISEASE PROGRESSION; FEMALE; HETEROGRAFTS; HUMANS; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, CONFOCAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PROGNOSIS; RNA-BINDING PROTEINS; TRANSFECTION;

EID: 84907087911     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2257     Document Type: Article

References (31)

1. Bernstein PL, Herrick DJ, Prokipcak RD and Ross J. Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. Genes Dev. 1992; 6(4):642-654.
2. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM and Nielsen FC. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol. 1999; 19(2):1262-1270.
3. Hu¨ttelmaier S, Zenklusen D, Lederer M, Dictenberg J, Lorenz M, Meng X, Bassell GJ, Condeelis J and Singer RH. Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1. Nature. 2005; 19(2):512-515.
4. Mu¨eller-Pillasch F, Lacher U, Wallrapp C, Micha A, Zimmerhackl F, Hameister H, Varga G, Friess H, Bu¨chler M, Beger HG, Vila MR, Adler G and Gress TM. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene. 1997; 14(22):2729-2733.
5. Yantiss RK, Woda BA, Fanger GR, Kalos M, Whalen GF, Tada H, Andersen DK, Rock KL and Dresser K. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol. 2005; 29(2):188-195.
6. Vikesaa J, Hansen TV, Jønson L, Borup R, Wewer UM, Christiansen J and Nielsen FC. RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J. 2006; 25(7):1456-1468.
7. Liao B, Hu Y, Herrick DJ and Brewer G. The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem. 2005; 280(18):18517-18524.
8. Suvasini R, Shruti B, Thota B, Shinde SV, Friedmann-Morvinski D, Nawaz Z, Prasanna KV, Thennarasu K, Hegde AS, Arivazhagan A, Chandramouli BA, Santosh V and Somasundaram K. Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2. J Biol Chem. 2011; 286(29):25882-25890.
9. Taniuchi K, Nishimori I and Hollingsworth MA. Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP. Cancer Res. 2011; 71(3):895-905.
10. Kedersha N and Anderson P. Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochem Soc Trans. 2002; 30(Pt 6):963-969.
11. Taniuchi K, Iwasaki S and Saibara T. BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation. Int J Oncol. 2011; 39(5):1243-1252.
12. Taniuchi K, Nishimori I and Hollingsworth MA. The N-terminal domain of G3BP enhances cell motility and invasion by posttranscriptional regulation of BART. Mol Cancer Res. 2011; 9(7):856-866.
13. Taniuchi K, Yokotani K and Saibara T. BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1. Neoplasia. 2012; 14(5):440-450.
14. Taniuchi K, Yokotani K and Saibara T. BART inhibits pancreatic cancer cell invasion by PKCα inactivation through binding to ANX7. PLoS One. 2012; 7(4):e35674.
15. Iwamura T, Katsuki T and Ide K. Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. Jpn J Cancer Res. 1987; 78(1):54-62.
16. Deer EL, Gonza´lez-Herna´ndez J, Coursen JD, Shea JE, Ngatia J, Scaife CL, Firpo MA and Mulvihill SJ. Phenotype and genotype of pancreatic cancer cell lines. Pancreas. 2010; 39(4):425-435.
17. Mazan-Mamczarz K, Lal A, Martindale JL, Kawai T and Gorospe M. Translational repression by RNA-binding protein TIAR. Mol Cell Biol. 2006; 26(7):2716-2727.
18. Kedersha N and Anderson P. Mammalian stress granules and processing bodies. Methods Enzymol. 2007; 431:61-81.
19. Anderson P and Kedersha N. Stress granules: the Tao of RNA triage. Trends Biochem Sci. 2008; 33(3):141-150.
20. Martin KC and Kosik KS. Synaptic tgging-who's it? Nat Rev Neurosci. 2002; 3(10):813-820.
21. Steward O and Schuman EM. Protein synthesis at synaptic sites on dendrites. Annu Rev Neurosci. 2001; 24:299-325.
22. Donaldson JG. Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J Biol Chem. 2003; 278(43):41573-41576.
23. Kawasaki Y, Senda T, Ishidate T, Koyama R, Morishita T, Iwayama Y, Higuchi O and Akiyama T. Asef, a link between the tumor suppressor APC and G-protein signaling. Science. 2000; 289(5482):1194-1197.
24. Hashimoto S, Onodera Y, Hashimoto A, Tanaka M, Hamaguchi M, Yamada A and Sabe H. Requirement for Arf6 in breast cancer invasive activities. Proc Natl Acad Sci USA. 2004; 101(17):6647-6652.
25. Kalluri R and Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-1428.
26. de Hoog CL, Foster LJ and Mann M. RNA and RNA binding proteins participate in early stages of cell spreading through spreading initiation centers. Cell. 2004; 117(5):649-662.
27. Parsons JT, Martin KH, Slack JK, Taylor JM and Weed SA. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene. 2000; 19(49):5606-5613.
28. Pruitt KD, Tatusova T and Maglott DR. NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 2007; 35:D61-65.
29. Mortazavi A, Williams BA, McCue K, Schaeffer L and Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008; 5(7):621-628.
30. Novichkova S, Egorov S and Daraselia N. MedScan, a natural language processing engine for MEDLINE abstracts. Bioinformatics 2003; 19(13):1699-1706.
31. Taylor AM, Dieterich DC, Ito HT, Kim SA and Schuman EM. Microfluidic local perfusion chambers for the visualization and manipulation of synapses. Neuron. 2010; 66(1):57-68